Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy

by | Oct 7, 2025 | Clinical Trials | 0 comments

​ Conditions: Duchenne Muscular Dystrophy

Interventions: Drug: WVE-N531

Sponsors: Wave Life Sciences Ltd.

Not yet recruiting Conditions: Duchenne Muscular Dystrophy
Interventions: Drug: WVE-N531
Sponsors: Wave Life Sciences Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *